Opendata, web and dolomites

CLINICOVERY SIGNED

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CLINICOVERY project word cloud

Explore the words cloud of the CLINICOVERY project. It provides you a very rough idea of what is the project "CLINICOVERY" about.

public    platform    sectors    clinical    yields    approval    international    99    clinicovery    obtaining    asia    industry    adverse    price    patient    health    commercial    modalities    pharmaceutical    complicate    remarkable    healthy    physiological    investment    endpoints    data    administrative    cagr    less    contains    stakeholders    million    workforce    company    maintenance    generating    market    compliance    2015    propelled    regulatory    accumulative    private    economic    travels    entities    versatile    reduce    2024    quantum    burden    expenses    participating    huge    returns    pacific    detect    pencil    faster    biomedical    capability    roi    monitoring    fda    gains    medical    45    ema    electronic    upgrades    2020    edc    gives    time    disease    outputs    rate    countries    capture    warning    jobs    paper    33    highest    region    16    performing    create    trials    effect    profit    least    chemical    multiple    provides    markets    cloud    agencies   

Project "CLINICOVERY" data sheet

The following table provides information about the project.

Coordinator
APPLOADING SL 

Organization address
address: C/ ISAAC NEWTON, S/N, EDIFICIO DISSET MOD C10 PARC
city: PALMA DE MALLORCA
postcode: 7121
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://apploading.com Isaac Newton street
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-04-01   to  2018-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    APPLOADING SL ES (PALMA DE MALLORCA) coordinator 50˙000.00

Map

 Project objective

The biomedical research is the key to reduce disease burden, and yields economic returns both through improved health gains (a healthy workforce) and through commercial exploitation of research outputs. The increasing disease burden has propelled the pharmaceutical industry to bring up new chemical entities into the market at a higher rate, increasing the number of clinical trials and generating huge quantum of clinical data. As a result, clinical trials are becoming increasingly complex, due the use of multiple data capture modalities (paper and pencil or/and Electronic Data Capture systems (EDC)), which require long implementation time, maintenance, upgrades and high economic investment, the need to evaluate more study endpoints and regulatory compliance with Medical Agencies and the growing number of stakeholders participating in the study. With CLINICOVERY, we will contribute to promote biomedical research in all the target sectors (Public and private) providing a versatile, regulatory compliance (FDA and EMA) cloud based platform that will reduce the implementation time (99%less) and costs (monitoring, price, travels, administrative expenses) and provides the capability to manage a huge and complicate data in large and international clinical trials to reach a faster market approval. Moreover, will be the unique platform in the market that contains a system to detect physiological patient data which gives advance warning of an adverse effect. The exploitation of the CLINICOVERY project will reach the EU countries, as the second region performing more clinical trials and then the Asia Pacific region, with the highest market growth (CAGR around 16% between 2015-2020) and US. In this way, the CLINICOVERY project will not only have a remarkable economic impact on our company (obtaining €7.33 million accumulative profit and ROI of 4.2 and create at least 45 new jobs by 2024), but will also contribute to increase our international presence, by targeting new markets.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CLINICOVERY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CLINICOVERY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

SensUS (2018)

SensUS: A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process.

Read More  

ImmuneHunter (2017)

Bioinformatics platform for profiling of health: allowing early and accurate detection of multiple diseases simultaneously

Read More